The European Medicines Agency has recommended the authorization of two new medicines against the coronavirus for people at risk of severe disease.
In a statement on Thursday, the EU drug regulator said it had concluded that the monoclonal antibody treatments -- a combination of casirivimab and imdevimab, and the drug regdanvimab -- have both been proven to significantly reduce the risk of hospitalization and death in patients vulnerable to serious COVID-19.
Read more at:
EU authorizes 2 medicines for people at risk of severe COVID-19 | CTV News
Showing posts with label Vaccines. Show all posts
Showing posts with label Vaccines. Show all posts
11/11/21
8/11/21
Vaccines give COVID-19 survivors a big immune boost, studies show
According to a new Gallup survey, one of the main reasons Americans cite for not planning to get vaccinated is the belief that they're protected since they already had COVID-19.
From the beginning health authorities have urged survivors to get the broader protection vaccination promises. While the shots aren't perfect, they are providing strong protection against hospitalization and death even from the delta mutant.
Read moreat: Vaccines give COVID-19 survivors a big immune boost, studies show | CBC News
From the beginning health authorities have urged survivors to get the broader protection vaccination promises. While the shots aren't perfect, they are providing strong protection against hospitalization and death even from the delta mutant.
Read moreat: Vaccines give COVID-19 survivors a big immune boost, studies show | CBC News
7/23/21
COVID-19 vaccine inequity: Inside the cutthroat race to secure doses
No one disputes that the world is unfair. But no one expected a vaccine gap between the global rich and poor that was this bad, this far into the pandemic.
Inequity is everywhere: Inoculations go begging in the United States while Haiti, a short plane ride away, received its first delivery July 15 after months of promises - 500,000 doses for a population over 11 million. Canada has procured more than 10 doses for every resident; Sierra Leone's vaccination rate just cracked 1% on June 20.
It's like a famine in which “the richest guys grab the baker,” said Strive Masiyiwa, the African Union's envoy for vaccine acquisition.
In fact, European and American officials deeply involved in bankrolling and distributing the vaccines against coronavirus have told The Associated Press there was no thought of how to handle the situation globally. Instead, they jostled for their own domestic use.
For the complete detailed report go to: COVID-19 vaccine inequity: Inside the cutthroat race to secure doses | CP24.com
Inequity is everywhere: Inoculations go begging in the United States while Haiti, a short plane ride away, received its first delivery July 15 after months of promises - 500,000 doses for a population over 11 million. Canada has procured more than 10 doses for every resident; Sierra Leone's vaccination rate just cracked 1% on June 20.
It's like a famine in which “the richest guys grab the baker,” said Strive Masiyiwa, the African Union's envoy for vaccine acquisition.
In fact, European and American officials deeply involved in bankrolling and distributing the vaccines against coronavirus have told The Associated Press there was no thought of how to handle the situation globally. Instead, they jostled for their own domestic use.
For the complete detailed report go to: COVID-19 vaccine inequity: Inside the cutthroat race to secure doses | CP24.com
6/9/21
Vaccines: COVID-19 Vaccines Are Better Than We Ever Expected
Amid a global tragedy, the striking effectiveness of vaccines against the coronavirus stands out as one of the pandemic’s few good-news stories for humanity.
And the vaccines are the success story that, so far, has kept on going. Vaccinations are proving to be just as effective in the real world as they were in clinical trials, while remaining highly protective against the more contagious variants spreading worldwide. And two recent studies found that immunity to the virus could last for years.
Read more at: COVID-19 Vaccines Are Better Than We Ever Expected
And the vaccines are the success story that, so far, has kept on going. Vaccinations are proving to be just as effective in the real world as they were in clinical trials, while remaining highly protective against the more contagious variants spreading worldwide. And two recent studies found that immunity to the virus could last for years.
Read more at: COVID-19 Vaccines Are Better Than We Ever Expected
5/13/21
Netherlands - Calvinists: In the Netherlands, traditional Calvinists refuse vaccines and social distancing
In the Netherlands, Protestants make up around 16 percent of the population and a small group of traditional Calvinists are opposed to vaccination and social distancing. Most of these believers, who live in a region known as the "Bible Belt", were never vaccinated as children and are opposed to the idea of injecting sickness into a healthy body. Despite surging case numbers, they continue to attend Sunday services without face masks. But amid some of the country's highest Covid-19 infection rates, some of them are starting to shift their mindset. Our regional correspondents report.
Read more at: In the Netherlands, traditional Calvinists refuse vaccines and social distancing - Focus
Read more at: In the Netherlands, traditional Calvinists refuse vaccines and social distancing - Focus
3/15/21
EU -Vaccines - Oxford/AstraZeneca: Spain joins France, Germany and Italy in pausing Oxford/AstraZeneca vaccine
France, Italy, Portugal, Slovenia and Cyprus announced they will stop administering the Oxford/AstraZeneca vaccine pending an assessment by the EU’s medicine regulator. Spain said it will stop using the AZ vaccine for at least two weeks.
The benefits of the Oxford/AstraZeneca vaccine in preventing Covid outweigh the risks of side effects, the European Medicines Agency said in a statement. The World Health Organization (WHO) has said there is no proven link to blood clots and that people should not panic.
Read more at: Spain joins France, Germany and Italy in pausing Oxford/AstraZeneca vaccine – as it happened | World news | The Guardian
The benefits of the Oxford/AstraZeneca vaccine in preventing Covid outweigh the risks of side effects, the European Medicines Agency said in a statement. The World Health Organization (WHO) has said there is no proven link to blood clots and that people should not panic.
Read more at: Spain joins France, Germany and Italy in pausing Oxford/AstraZeneca vaccine – as it happened | World news | The Guardian
2/8/21
From China and Russia with love: Covid-19: Can Vaccines from Russia and China Be a Game Changer? by Jörg Blech
A huge number of people in Germany and other European countries can hardly wait to get vaccinated against COVID-19. In Serbia, by contrast, it has sometimes appeared difficult to find someone willing to accept the jab. The syringes in the country, after all, were not filled with a product from Western pharmaceutical companies, but with a vaccine developed by the Chinese company Sinopharm. Nevertheless, Serbian Health Minister Zlatibor Lončar elected to become the first person in his country to receive the vaccine.
"I was guided by two basic facts. First, that the vaccine meets all the safety criteria. And second, that it is effective," says Lončar, a medical doctor. He received his injection in January. "When I was convinced of all the above, I was able to stand up before the citizens of Serbia and suggest that they start mass vaccination."
Read more at: Covid-19: Can Vaccines from Russia and China Be a Game Changer? - DER SPIEGEL
"I was guided by two basic facts. First, that the vaccine meets all the safety criteria. And second, that it is effective," says Lončar, a medical doctor. He received his injection in January. "When I was convinced of all the above, I was able to stand up before the citizens of Serbia and suggest that they start mass vaccination."
Read more at: Covid-19: Can Vaccines from Russia and China Be a Game Changer? - DER SPIEGEL
2/5/21
EU: In Europe Union, vaccines from Russia and China are now under study - by Loveday Morris
As the European Union's vaccination program stumbles, Russia and China are poised to fill the gap — with Moscow opening talks to produce vaccines in the heart of Europe and both building political cachet as they supply those scrambling for shots on the bloc's fringes.
Vaccines produced in Russia and China are already on the program in parts of the Balkans and Eastern Europe outside the European Union.
Speaking to the Atlantic Council on Thursday, Macron called China’s vaccine efforts a “clear diplomatic success” which is “a little bit humiliating for us.” He and German Chancellor Angela Merkel have expressed their openness to using vaccines from Moscow and Beijing if E.U. regulatory approval is granted.
Read more at: In Europe Union, vaccines from Russia and China are now under study - The Washington Post
Vaccines produced in Russia and China are already on the program in parts of the Balkans and Eastern Europe outside the European Union.
Speaking to the Atlantic Council on Thursday, Macron called China’s vaccine efforts a “clear diplomatic success” which is “a little bit humiliating for us.” He and German Chancellor Angela Merkel have expressed their openness to using vaccines from Moscow and Beijing if E.U. regulatory approval is granted.
Read more at: In Europe Union, vaccines from Russia and China are now under study - The Washington Post
1/29/21
EU approves AstraZeneca coronavirus vaccine
COVID-19 Vaccine AstraZeneca is now authorised across the EU. This follows the granting of a conditional marketing authorisation by the European Commission on 29 January 2021.
EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. This is the third COVID-19 vaccine that EMA has recommended for authorisation.
EMA’s human medicines committee (CHMP) has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission. This will assure EU citizens that the vaccine meets EU standards and puts in place the safeguards, controls and obligations to underpin EU-wide vaccination campaigns.
Read more at: EU approves AstraZeneca coronavirus vaccine | News | DW | 29.01.2021
EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. This is the third COVID-19 vaccine that EMA has recommended for authorisation.
EMA’s human medicines committee (CHMP) has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission. This will assure EU citizens that the vaccine meets EU standards and puts in place the safeguards, controls and obligations to underpin EU-wide vaccination campaigns.
Read more at: EU approves AstraZeneca coronavirus vaccine | News | DW | 29.01.2021
1/21/21
The ABC of Covid-19 Vaccines: Covid vaccine differences? Pfizer v Oxford v Moderna
The three Covid-19 vaccines are from Pfizer-BioNTech, the University of Oxford and Astra-Zeneca and Moderna.
The Pfizer, Oxford and Moderna vaccines each require two doses and you are not fully vaccinated until you've had both shots.
But there are many differences between them.
READ MORE AT: Covid vaccine differences? Pfizer v Oxford v Moderna - BBC News
The Pfizer, Oxford and Moderna vaccines each require two doses and you are not fully vaccinated until you've had both shots.
But there are many differences between them.
READ MORE AT: Covid vaccine differences? Pfizer v Oxford v Moderna - BBC News
1/11/21
Vaccines - a more effective approach: Pfizer, Moderna mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow -by Andreas Kluth
The most promising Covid vaccines use nucleic acids called messenger RNA, or mRNA. One vaccine comes from the German firm BioNTech SE and its U.S. partner Pfizer Inc. The other is from the U.S. company Moderna Inc. (its original spelling was ModeRNA, its ticker is MRNA). Another is on the way from CureVac NV, also based in Germany.
Br>
Ordinary vaccines tend to be inactivated or weakened viruses which, when injected into the body, stimulate an immune response that can later protect against the live pathogen. But the process of making such vaccines requires various chemicals and cell cultures. This takes time and provides opportunities for contamination.
mRNA vaccines don’t have these problems. They instruct the body itself to make the offending proteins — in this case, the ones that wrap around the viral RNA of SARS-CoV-2. The immune system then homes in on these antigens, practicing for the day when the same proteins show up with the coronavirus attached.
Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides Covid-19.
Read more at: Pfizer, Moderna mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow - Bloomberg
Ordinary vaccines tend to be inactivated or weakened viruses which, when injected into the body, stimulate an immune response that can later protect against the live pathogen. But the process of making such vaccines requires various chemicals and cell cultures. This takes time and provides opportunities for contamination.
mRNA vaccines don’t have these problems. They instruct the body itself to make the offending proteins — in this case, the ones that wrap around the viral RNA of SARS-CoV-2. The immune system then homes in on these antigens, practicing for the day when the same proteins show up with the coronavirus attached.
Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides Covid-19.
Read more at: Pfizer, Moderna mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow - Bloomberg
4/25/15
Mercury in Vaccines: Anti-vax group defends comparing immunisation withThimerosam additive to rape
In a press release issued recently, one
that almost no mainstreain Australia m media sources have bothered to report, it was
announced that Dr. Brian Hooker had finally received documents from the
CDC through a Freedom of Information Act that revealed the CDC had
access to data linking Thimerosal in vaccines to autism, non-organic
sleep disorders, and speech disorders.
Two members of Congress helped Dr. Hooker
draft his letter to the CDC, after having spent nearly 10 years
submitting over 100 Freedom of Information Acts to no avail.
This information is very damaging to the CDC, which has stated for years
that there are no studies linking the mercury of Thimerosal in vaccines
to autism.
In another recent testimony given by the CDC in the November 2012 Congressional
Hearing on Autism, they claimed there are no studies linking
Thimerosal to autism. Thimerosam however is still used today in the flu shot
that is administered to pregnant women and infants.
An Anti-vaccination group in Australia has defended an advert which appears to compare immunising children with being raped.
The Australian Vaccination Skeptics Network posted an image of a woman with a man threateningly holding his hand over her mouth on its Facebook page earlier today.
This information, so far, has been completely blacked out of the mainstream media.
EU-Digest
Subscribe to:
Posts (Atom)